$82.03
+1.45 (+1.80%)
Performance
1D
—
1W
—
1M
—
3M
+21.63%
6M
+21.04%
1Y
+30.83%
YTD
+21.06%
Open$80.66
Previous Close$80.58
Day High$82.26
Day Low$80.50
52W High$77.41
52W Low$53.40
Volume—
Avg Volume4.15M
Market Cap51.80B
P/E Ratio47.35
EPS$1.58
SectorChemicals
Technical Indicators
Full analysis →
SMA 50
$70.18
Above
SMA 200
$69.50
Above
RSI (14)
62.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
31 analysts
Price Target
-36.6% upside
Current
$82.03
$82.03
Target
$52.01
$52.01
$36.54
$52.01 avg
$63.60
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.27B | 17.29B | 22.74B |
| Net Income | 1.09B | 978.20M | 2.33B |
| Profit Margin | 6.3% | 6.0% | 10.2% |
| EBITDA | 2.52B | 2.40B | 4.01B |
| Free Cash Flow | — | — | 2.20B |
| Rev Growth | -0.1% | -0.1% | -6.0% |
| Debt/Equity | 0.11 | 0.11 | 0.26 |
Dividend
Dividend Yield0.93%
Annual Dividend$0.70
Payout Ratio43.4%
Frequencysemi-annual
Ex-DividendMar 12, 2026
Pay DateMar 31, 2026
About Corteva Inc
Corteva, Inc. is a leading global provider of seed and crop protection products, headquartered in Indianapolis, Indiana, serving agricultural customers across more than 140 countries. The company operates through two segments: Seed, offering proprietary germplasm and biotechnology traits for corn, soybeans, sunflowers, and other crops; and Crop Protection, providing herbicides, insecticides, and fungicides. Corteva was formed through the combination of Dow AgroSciences, DuPont Crop Protection, and Pioneer Hi-Bred, uniting several of the most recognized names in agricultural science. It is one of the largest pure-play agricultural sciences companies in the world.
Chemicals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LIN | Linde Plc | $492.34 | +2.61% | 32.9 | 226.97B |
| SHW | Sherwin-Williams Co/The | $321.95 | +2.63% | 32.4 | 83.12B |
| ECL | Ecolab Inc | $268.54 | +1.53% | 38.4 | 79.70B |
| APD | Air Products & Chemicals Inc | $290.09 | +1.34% | — | 61.04B |
| NTR | Nutrien Ltd | $76.62 | -0.26% | 18.8 | 46.56B |
| PPG | Ppg Industries Inc | $106.69 | +3.16% | 13.9 | 21.85B |
CTVA Frequently Asked Questions
What does Corteva do?
Corteva sells the seeds that farmers plant and the herbicides, fungicides, and insecticides that protect those crops through the growing season — the two essential inputs that determine agricultural yields. The company's Pioneer brand corn and soybean seeds are among the most recognized in North American agriculture, supported by decades of proprietary breeding and biotechnology-enhanced traits. The crop protection portfolio has also grown globally, and Corteva invests in biological solutions — naturally derived crop protectants — as a complement to conventional chemistry across a growing number of markets.
Is CTVA stock a good investment?
Corteva's performance is tied to agricultural commodity markets, farmer profitability, and planting intentions — variables that move with corn and soybean prices, global demand, and weather. When farmers earn well, they invest in premium seed genetics and crop protection; when commodity prices fall, they trade down or reduce inputs. The company has strong market positions in both seeds and crop protection, but generic herbicide competition has pressured some product categories. Pricing power on new biotech trait introductions is higher, and Corteva's trait pipeline is critical to sustaining premium seed economics.
Who are Corteva's main competitors?
Bayer CropScience (including the Monsanto seed and herbicide assets it acquired) is Corteva's largest global competitor, offering competing seed genetics and the iconic Roundup herbicide franchise. Syngenta, now owned by ChemChina, competes across both seeds and crop protection globally. BASF Agricultural Solutions is a major crop protection competitor. FMC Corporation competes in insecticides and herbicides. In Brazil, a large and growing market for Corteva, competition from domestic generic chemistry suppliers intensifies competitive pressure on crop protection margins.
Does Corteva pay dividends?
Corteva has paid a quarterly dividend since its 2019 spinoff from DowDuPont, growing it gradually as the company established its standalone financial profile and generated consistent free cash flow. The yield is modest, reflecting a business where management sees attractive reinvestment opportunities in seed trait development and crop protection innovation that compete with shareholder returns for capital allocation priority. Share repurchases supplement dividends, and the overall capital return program is designed to grow alongside earnings as the company matures its standalone financial structure.
Where is CTVA trading today?
CTVA is currently trading at $82.03, up 1.80% in today's session. Over the past 52 weeks, the stock has traded between a low of $53.40 and a high of $77.41. The current price represents 100% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.
What are analyst ratings for CTVA stock?
Among 31 analysts covering CTVA, the consensus rating is Buy — 22 rate it a buy, 9 hold, and 0 sell. The average price target sits at $52.01, implying 37% downside from the current price. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.
How much revenue does Corteva Inc generate?
Corteva Inc generated $17.27B in revenue during fiscal year 2026, with $1.09B reaching the bottom line as net income. The net profit margin of 6.3% reflects the competitive nature of its industry.
What is the price-to-earnings ratio for CTVA?
CTVA trades at a P/E ratio of 47.35 on trailing earnings of $1.58 per share. That's above the S&P 500 historical average, suggesting the market expects above-average earnings growth ahead. Comparing this multiple against Chemicals sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.
How has CTVA performed compared to last year?
Performance varies across timeframes, reflecting shifting market conditions. Returns by timeframe: +21.63% (3M), +21.04% (6M), +30.83% (1Y), +21.06% (YTD). Comparing these figures against the S&P 500 and sector benchmarks helps determine whether CTVA is outperforming or lagging the broader market.